NovoCure (NVCR) EPS (Basic) (QoQ) (2014 - 2026)
NovoCure (NVCR) EPS (Basic) (QoQ) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.74 Bn | 176.45 Bn | 6.27 Bn |
| 2 | Stryker | 128.89 Bn | 126.01 Bn | 3.81 Bn |
| 3 | Medtronic | 108.48 Bn | 99.26 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.51 Bn | 67.05 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.32 Bn | 44.65 Bn | 1.29 Bn |
| 6 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.23 Bn | 25.95 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.90 Bn | 26.32 Bn | - |
| 9 | Koninklijke Philips | 24.47 Bn | 21.35 Bn | 2.07 Bn |
| 10 | NovoCure | 2.02 Bn | 1.58 Bn | 142.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 78.34% |
| Mar 31, 2026 | -183.56% |
| Dec 31, 2025 | 34.01% |
| Sep 30, 2025 | 7.43% |
| Jun 30, 2025 | -15.61% |
| Mar 31, 2025 | 49.10% |
| Dec 31, 2024 | -116.47% |
| Sep 30, 2024 | 8.87% |
| Jun 30, 2024 | 14.24% |
| Mar 31, 2024 | 18.34% |
| Dec 31, 2023 | 4.52% |
| Sep 30, 2023 | 14.21% |
| Jun 30, 2023 | -7.58% |
| Mar 31, 2023 | -40.89% |
| Dec 31, 2022 | -40.66% |
| Sep 30, 2022 | -10.43% |
| Jun 30, 2022 | -414.45% |
| Mar 31, 2022 | 82.56% |
| Dec 31, 2021 | -102.18% |
| Sep 30, 2021 | 10.57% |